Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6801-6808

  Miao, Zhi Feng ^a   Zhao, Ting Ting ^a   Wang, Zhen Ning ^a   Xu, Ying Ying ^a   Mao, Xiao Yun ^a   Wu, Jian Hua ^a   Liu, Xing Yu ^a   Xu, Hao ^a   You, Yi ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Hypoxia; Intermittent hypoxia; Metastasis; Reoxygenation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1BETA; OCTAMER TRANSCRIPTION FACTOR 4;

APOPTOSIS; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; INTERMITTENT HYPOXIA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR SPHEROID; WOUND HEALING;

CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84905059772     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1928-7     Document Type: Article

References (27)

1. Han MA, Oh MG, Choi IJ, et al. Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol. 2012;30:701-8.
2. Wang W, Li Z, Tang J, et al. Laparoscopic versus open total gastrectomy with D2 dissection for gastric cancer: a meta-analysis. J Cancer Res Clin Oncol. 2013;139:1721-34.
3. Shitara K, Matsuo K, Muro K, et al. Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy. J Cancer Res Clin Oncol. 2013;139:1383-9.
4. Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702-13. (Pubitemid 47460649)
5. Merchant JL, Saqui-Salces M. Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment. Cancer Treat Rev. 2014;40:12-21.
6. Singh SR. Gastric cancer stem cells: a novel therapeutic target. Cancer Lett. 2013;338:110-9.
7. Achyut BR, Yang L. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141:1167-78.
8. Das B, Tsuchida R, Malkin D, et al. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells. 2008;26:1818-30.
9. Schwab LP, Peacock DL, Majumdar D, et al. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res. 2012;14:R6.
10. Zhang H, Wu H, Zheng J, et al. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma. Stem Cells. 2013;31:433-46.
11. Pistollato F, Rampazzo E, Persano L, et al. Interaction of hypoxiainducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells. 2010;28:1918-29.
12. Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest. 2013;123:3664-71.
13. Rohwer N, Zasada C, Kempa S, et al. The growing complexity of HIF-1α's role in tumorigenesis : DNA repair and beyond. Oncogene. 2013;32:3569-76.
14. Mayer A, Schneider F, Vaupel P, et al. Differential expression of HIF-1 in glioblastomamultiforme and anaplastic astrocytoma. Int J Oncol. 2012;41:1260-70.
15. Rademakers SE, Lok J, van der Kogel AJ, et al.Metabolicmarkers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF- 1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer. 2011;11:167.
16. Kitajima Y, Miyazaki K. The critical impact of HIF-1α on gastric cancer biology. Cancers (Basel). 2013;5:15-26.
17. Rohwer N, Lobitz S, Daskalow K, et al. HIF-1 alpha determines the metastatic potential of gastric cancer cells. Br J Cancer. 2009;100:772-81.
18. Bhaskara VK, Mohanam I, Rao JS, et al. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells. PLoS ONE. 2012;7:e30905.
19. Louie E, Nik S, Chen JS, et al. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res. 2010;12:R94.
20. Shi J, Wan Y, Di W. Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells. Oncol Rep. 2008;20:803-7.
21. Schmuck R, Warneke V, Behrens HM, et al. Genotypic and phenotypic characterization of side population of gastric cancer cell lines. Am J Pathol. 2011;178:1792-804.
22. Barker N, Huch M, Kujala P, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010;6:25-36.
23. Ehata S, Johansson E, Katayama R, et al. Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene. 2011;30:1693-705.
24. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38-47. (Pubitemid 37328806)
25. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9:685-93. (Pubitemid 36749217)
26. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704-15. (Pubitemid 351636299)
27. Radisky DC, LaBarge MA. Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell. 2008;2:511-2. (Pubitemid 351729219)